Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 17,952 shares at $34.41 ($618K) on 2024-09-18, disclosed to the SEC on 2024-09-19.
Scheduled sale ($618k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.41 | 4,340 | $149K | 24.2% |
| 2 | $34.41 | 4,340 | $149K | 24.2% |
| 3 | $34.41 | 4,636 | $160K | 25.8% |
| 4 | $34.41 | 4,636 | $160K | 25.8% |
| Total | $34.41 avg | 17,952 | $618K | 100% |
| Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |
| DYN | SELL | 2024-06-13 | $2.7M | — | Filing → |